Venture Huikang (300451): Medical IT business grows steadily, new products and new businesses launch at an accelerated pace
Venture Huikang (300451): Performance verification, recovery expectations, HI-HIS product release can be expected
Venture Huikang (300451): Q1 performance gradually recovers, annual profit is expected to improve
Chuangye Huikang (300451) 2023 Report Review: Steady Revenue Growth HI-HIS Towards a New Stage of Promotion
Southwest Securities released a research report on April 21 stating that it maintains the Venture Huikang (300451.SZ) purchase rating, and the target price is 5.20 yuan. The main reasons for the rating include: 1) revenue growth has resumed, and profits a
Venture Huikang (300451): HI-HIS starts large-scale promotion; increased orders support future performance
Venture Huikang (300451): Consolidate leading advantages in multiple ways and profitability is expected to be restored
Venture Huikang (300451): Demand recovers, revenue growth awaits batch delivery by HI-HIS
Venture Huikang (300451): Profitability is expected to recover quickly in the new phase of HI-HIS promotion
Entrepreneurship Huikang (300451): Demand shows a positive trend and strengthens the core development ecosystem
Entrepreneurship Huikang (300451): Revenue growth resumed for 24 years or reached an inflection point in profit
Venture Huikang (300451) first coverage: grasping the needs of the “promoting construction through evaluation” industry and starting the HDAI ecosystem integration strategy
Entrepreneurship Huikang (300451): Quarterly revenue increased significantly and returned to the growth channel
Entrepreneurship Huikang (300451): Medical IT Industry Recovery, HI-HIS and CTASY Create Incremental Value
Entrepreneurship Huikang (300451): Revenue growth is improving quarterly, waiting for orders to pick up and AI progress
Entrepreneurship Huikang (300451): Q3 revenue accelerates growth, AI+ healthcare opens up room for growth
Entrepreneurship Huikang (300451): Gradual recovery of performance and orders, intensive implementation of HI-HIS
Deep* Company* Entrepreneurship Huikang (300451): Accelerating Revenue Growth, New Product HI-HIS Accelerating Promotion and Delivery
Entrepreneurship Huikang (300451): Q3 revenue accelerated again and business improved throughout the year
Entrepreneurship Huikang (300451): Signs of demand recovery show a recovery in Q2 performance
No Data